MemeCore (M) surges nearly 30% to $1.176 ATH, but RSI at 87.28 signals extreme overbought conditions and risk of reversal. Negative funding rate of 0.094% shows traders heavily shorting M, reflecting ...

Electric vehicle (EV) manufacturer Lucid Group (LCID 0.26%) is making headlines again... but not the kind investors like to see. The maker of the luxury Lucid Air sedan and Lucid Gravity SUV is ...

Shares of Amcor plc (NYSE:AMCR) are little changed on Tuesday. This follows a significant decline that was triggered by a weak earnings report. Some traders are anticipating a reversal and move higher ...

The Bitcoin options skew and stablecoin activity show fear remains contained, pointing to limited downside pressure. Spot BTC ETF flows and top trader positioning confirm liquidity and resilience, ...

Angelica Leicht is the senior editor for the Managing Your Money section for CBSNews.com, where she writes and edits articles on a range of personal finance topics. Angelica previously held editing ...

On August 12, 2025, the Board approved a reverse stock split of the Company’s outstanding shares of Common Stock at a ratio of one-for-five (the “Reverse Stock Split”). The Reverse Stock Split is ...

In the physical world, time marches in one direction, but things aren’t so straight forward in the quantum realm. Researchers have discovered that it’s possible to speed up, slow down, or reverse the ...

The original version of this story appeared in Quanta Magazine. At the turn of the 20th century, the renowned mathematician David Hilbert had a grand ambition to bring a more rigorous, mathematical ...

Despite a 10% plunge in XRP over the past 24 hours, the Ripple-linked cryptocurrency is still on track to regroup and surpass its 2018 all-time high, according to a crypto executive. “While it’s ...

An analyst known for betting against Bitcoin (BTC) says he’s still bearish after the flagship crypto asset’s major breakout. The analyst pseudonymously known as Capo tells his 128,461 Telegram ...

Onconetix shares tumbled nearly 20% on Wednesday after the biotechnology company said it would combine with biopharmaceutical company Ocuvex Therapeutics in an all-stock reverse merger. Onconetix said ...